Meta-analysis finds shared endocannabinoid gene changes across myopathies
Endocannabinoid system remodeling in human myopathies: a meta-analysis of skeletal muscle transcriptomes.
AI Summary
This retrospective meta-analysis asked whether the endocannabinoid system is altered in human muscle diseases. Researchers reanalyzed public muscle RNA-sequencing datasets, comparing biopsies from people with several types of myopathy with samples from controls. The main finding was a consistent pattern across disease subtypes: CNR1, which encodes the CB1 receptor, was upregulated, while FAAH, an enzyme that breaks down anandamide and related molecules, was downregulated. The abstract reports 328 patient biopsies and 173 control samples.
The results suggest that altered endocannabinoid signaling may be a shared feature of muscle degeneration, while enzymes involved in 2-AG metabolism varied by disease. This is a meta-analysis of gene-expression data, not a trial of cannabis or cannabinoid treatment. It cannot show whether these expression changes cause myopathy, affect symptoms, or indicate a useful treatment target; the authors call for studies linking endocannabinoid changes over time with clinical measures. This is an abstract-based summary, not a review of the full text.
๐ก Key Findings
๐
Original Abstract
Related Research
Similar Studies
More Endocannabinoid research papers you might find interesting.
Small biomarker analysis finds no significant changes after 10 HBOT sessions
Rat study finds mixed behavioral and biological effects of WIN under chronicโฆ
Brain blood-flow reductions in acute anorexia follow a cortical hierarchy
Explore More Research
Stay informed about the latest cannabis science.